Validation of Scoring Systems for Differentiating Intestinal Tuberculosis from Crohn's Disease
Launched by MAHIDOL UNIVERSITY · Oct 4, 2024
Trial Information
Current as of July 09, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking to improve the way doctors can tell the difference between two similar conditions: Crohn's disease and intestinal tuberculosis. These conditions can cause similar symptoms, making it hard to diagnose correctly. If someone is misdiagnosed with Crohn's disease when they actually have intestinal tuberculosis, they might receive the wrong treatment, which can lead to serious health issues. The trial aims to test new models that combine different tests and information from patients to help make a more accurate diagnosis.
To join this study, participants must be at least 18 years old and have ulcers in their intestines that have been examined through a procedure called colonoscopy. They also need to have tissue samples tested for tuberculosis. The researchers will be looking for people who have already started treatment for either condition and responded well. If you decide to participate, you will help improve the understanding of these diseases and potentially help others in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Patients ages 18 years or older
- • 2. Undergoing colonoscopy and found ileal or colonic ulcers
- • 3. Have ileal and/or colonic tissue sent for mycobacterial tests, including stain for AFB, PCR, and culture
- • 4. Diagnosed with either intestinal tuberculosis or Crohn's disease a. Criteria of intestinal tuberculosis diagnosis includes any of following: i. Presence of caseating granuloma on pathological examination of specimens ii. Presence of acid-fast bacilli on pathological examination of specimens iii. PCR positive for Mycobacterium tuberculosis iv. Tissue culture growing organisms consistent with Mycobacterium tuberculosis v. Negative results in i to iv but response to empirical treatment with antituberculous therapy All are required to have clinical and endoscopic response to antituberculous therapy (ATT) treatment b. Diagnosis of Crohn's disease is based on clinical, endoscopic, pathological, and/or radiological findings which is confirmed by clinical \& endoscopic response to Crohn's disease treatment
- Exclusion Criteria:
- • 1. Patients with ileal/colonic ulcers caused by other diseases
About Mahidol University
Mahidol University, a premier institution in Thailand, is dedicated to advancing healthcare through innovative research and education. As a leading sponsor of clinical trials, the university leverages its extensive expertise in medical and health sciences to facilitate rigorous scientific investigations aimed at improving patient care and public health outcomes. With a commitment to ethical practices and collaboration, Mahidol University fosters multidisciplinary approaches, engaging a diverse array of researchers and healthcare professionals to drive meaningful advancements in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bangkok, , Thailand
Bangkok Noi, Bangkok, Thailand
Patients applied
Trial Officials
Julajak Limsrivilai
Principal Investigator
Division of Gastroenterology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported